Repurposing metformin: a potential off-label indication for ischaemic stroke?
Oo TT
Diabetes Obes Metab. Pub. online 26 Nov 2024.
Leggi
Breaking news
Managing diabetic chronic kidney disease in pregnancy: current clinical practice and uncertainties
Banerjee A, Brackenridge A
Diabet Med. 2024:e15460.
Leggi
Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association
Neumiller JJ, Bajaj M, Bannuru RR, et al.
Diabetes Care. 2024:dci240091.
Leggi
The relationship of changes in insulin demand and insulin adequacy over the life course
Zhang Y, Tam CHT, Lau ESH, et al.
Diabetologia. Pub. online 29 Nov 2024.
Leggi
2-fold more cardiovascular disease events decades before type 2 diabetes diagnosis: a nationwide registry study
Gyldenkerne C, Kahlert J, Thrane PG, et al.
J Am Coll Cardiol. 2024;84(23):2251-2259.
Leggi
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Badve SV, Bilal A, Lee MMY, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00271-7.
Leggi
Cognitive changes in people with diabetes with lower extremity complications compared to people with diabetes without lower extremity complications: a systematic review and meta-analysis
Karunathilaka N, Parker C, Lazzarini PA, et al.
BMC Endocr Disord. 2024;24(1):258.
Leggi
Diabetes body project: acute effects of an eating disorder prevention program for young women with type 1 diabetes: a multinational randomized controlled trial
Hennekes MHCL, Haugvik S, de Wit M, et al.
Diabetes Care. 2024:dc241599.
Leggi
Diabetes body project: acute effects of an eating disorder prevention program for young women with type 1 diabetes: a multinational randomized controlled trial
Hennekes MHCL, Haugvik S, de Wit M, et al.
Diabetes Care. 2024:dc241599.
Leggi